[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362488-105":59,"doc-detail-362488-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","late-distant-recurrence-prediction-model-in-premenopausal-women-with-er-positiveher-2-negative-breast-cancer-a-multicenter-retrospective-study","Late distant recurrence prediction model in premenopausal women with ER-positive/HER 2-negative breast cancer - A multicenter retrospective study","","Late distant recurrence (DR) remains a significant challenge in ER-positive/HER2-negative breast cancer, particularly for premenopausal patients. This retrospective multicenter study developed a machine-learning model to predict late DR risk and evaluated whether extended endocrine therapy benefit varies by risk stratification. Patients aged ≤45 years treated surgically from 2000–2011 were analyzed with a baseline at 5 years post-surgery and late DR defined as events from 5–10 years.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/late-distant-recurrence-prediction-model-in-premenopausal-women-with-er-positiveher-2-negative-breast-cancer-a-multicenter-retrospective-study/362488/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/late-distant-recurrence-prediction-model-in-premenopausal-women-with-er-positiveher-2-negative-breast-cancer-a-multicenter-retrospective-study/362488.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study?","Question",{"text":112,"@type":113},"To develop a machine-learning model predicting late distant recurrence risk in premenopausal patients and to assess the clinical benefit of extended endocrine therapy by risk group.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was “late distant recurrence” defined?",{"text":117,"@type":113},"As distant metastasis occurring between 5 and 10 years after surgery.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show regarding extended endocrine therapy?",{"text":121,"@type":113},"Extended endocrine therapy significantly improved late DMFS in high-risk patients, while low-risk patients did not show a statistically significant benefit.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362488,1790176405,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","The Breast 86 (2026) 104738  \nContents lists available at ScienceDirect  \nThe Breast  \njournal [homepage:](homepage: www.journals.elsevier.com/the-breast)[ www.journals.elsevier.com/the-breast](homepage: www.journals.elsevier.com/the-breast)  \nLate distant recurrence prediction model in premenopausal women with ER-positive/HER 2-negative breast cancer: A multicenter  \nretrospective study  \nDong Seung Shina,1,2 , Janghee Lee b,1, Eunhye Kangc,1, Dasom Nohd,1, Jong-Ho Cheune, Jun-Hee Lee f, Yeongyeong Son d, Soong June Baeg, Sunyoung Kwon d,h,i, Han-Byoel Leec,j,k,*, Jai Min Ryu a,**, Sung Gwe Ahn g,l,***   \na Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University of Medicine, Seoul, Republic of Korea  \nb Department of Surgery, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea  \nc Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea  \nd Department of Information Convergence Engineering, College of Information and Biomedical Engineering, Pusan National University, Busan, Republic of Korea e Department of Surgery, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Republic of Korea  \nf Department of Surgery, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea  \ng Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea  \nh School of Biomedical Convergence Engineering, College of Information and Biomedical Engineering, Pusan National University, Yangsan, Republic of Korea i Center for Artificial Intelligence Research, Pusan National University, Busan, Republic of Korea  \nj Cancer Research Institute, Seoul National University, Seoul, Republic of Korea  \nk Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea  \nl Institute for Breast Cancer Precision Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea  \nA R T I C L E I N F O  \nKeywords:  \nBreast cancer  \nLate distant recurrence  \nMachine-learning prediction model Premenopausal  \nExtended endocrine therapy  \nA B S T R A C T  \nBackground: Late distant recurrence (DR) remains a significant challenge in estrogen receptor (ER)–positive/ Human Epidermal Growth Factor Receptor 2 (HER2)–negative breast cancer, especially in premenopausal patients. This study aimed to develop a machine-learning model predicting late DR risk in premenopausal patients and to assess the clinical benefit of extended endocrine therapy (ET) according to risk stratification.  \nMethods: This retrospective multicenter study included patients aged ≤45 years with ER–positive/HER2–-negative breast cancer who underwent surgery between January 2000 and December 2011. This study was designed as a landmark analysis, with the effective baseline set at 5 years after surgery. Eligible patients had five to 10 years of follow-up and received adjuvant ET for at least two years. The primary outcome was late DR, defined as distant metastasis occurring between five and 10 years after surgery.  \nResults: Among 1701 included patients (median age, 41 years), late DR occurred in 108 patients (6.3%). A machine-learning model using eight clinicopathologic variables demonstrated strong predictive performance (AUC = 0.78). Patients classified as high-risk by the model exhibited significantly worse late DMFS compared to low-risk patients (HR,7.36; 95% CI,4.43–12.20; P\u003C0.001). Among high-risk patients, those who received extended ET had significantly improved late DMFS compared to those who did not (HR,0.32; 95% CI,0.18–0.55; P \u003C 0.001). In low-risk patients, extended ET was not associated with a statistically significant benefit (HR,0.45; 95% CI,0.16–1.22; P = 0.081).  \n* Corresponding author. Department of Surgery, Seoul National U","cbCaierbTQavQwUC","https://ap.wps.com/l/cbCaierbTQavQwUC","pdf",2847513,"English","# Background\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the main goal of the study?\",\"answer\":\"To develop a machine-learning model predicting late distant recurrence risk in premenopausal patients and to assess the clinical benefit of extended endocrine therapy by risk group.\"},{\"question\":\"How was “late distant recurrence” defined?\",\"answer\":\"As distant metastasis occurring between 5 and 10 years after surgery.\"},{\"question\":\"What did the results show regarding extended endocrine therapy?\",\"answer\":\"Extended endocrine therapy significantly improved late DMFS in high-risk patients, while low-risk patients did not show a statistically significant benefit.\"}]","Late distant recurrence prediction model in premenopausal women with ER-positive/HER 2-negative breast cancer - A multicenter retrospective study | PDF",1790147946,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a363bdea572ccee061aa55e572a9ae9.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c66f399553c05fe9fb647bf0098e3e7c.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4004dcfc4f21f92d68fb714ddabe16a2.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2074733ff65bbdf1c5afff32dd5f7e08.webp",980,1306]